In this Issue
Innovations that Will Shape the Future of the Specialty
Data presented at the recent ECTRIMS offer fresh insight and potentially new direction into the cause of multiple sclerosis.
By Daniel Kantor, MD
VIDEO CASE CHALLENGE
By Khizar Malik, MD; Cara Sherrill; and Fabian Rossi, MD
Two experts sound off on the implications of indefinite treatment and whether DMTs should be stopped.
With Robert Naismith, MD and John Corboy, MD
The Prevalence of Migraine and Other Neurological Conditions Among Retired National Football League Players: A Pilot Study
Findings suggest that retired NFL players may be at increased risk for migraine, depression, anxiety, chronic pain, bedwetting, essential tremor, and Parkinson’s disease.
By Randolph W. Evans, MD
A review of notable neurological developments in 2017 and a preview of the year ahead.
Distinguishing between definite MMD, probable MMD, and MMS may not have significant practical implications.
By Timothy G. White, MD; Julia R. Schneider, BS; Kay O. Kulason, BA; Ralph Rahme, MD; Kevin Kwan, MD; Rafael A. Ortiz, MD; David J. Langer, MD; and Steven Mandel, MD
Although unrecognized hearing loss can affect quality of life and play a role in cognitive impairment, it may be reversible and/or treatable.
By Ronald Devere, MD
MOVEMENT DISORDERS FOCUS
An expanding research and therapeutic landscape has increased awareness and treatment of Huntington’s disease.
By Leonel Estofan, MD and Jill Giordano Farmer, DO, MPH
Where #Neurology and Culture Intersect